| Dr Usaima Naveed Siddiqi, DO | |
|
1606 N 7th St, Terre Haute, IN 47804 | |
| (812) 238-7523 | |
| Not Available |
| Full Name | Dr Usaima Naveed Siddiqi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 1606 N 7th St, Terre Haute, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063707347 | NPI | - | NPPES |
| OT014353 | Other | PA | LICENSE # |
| 300017314 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Heath | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aria Health Physician Services | 3577467018 | 418 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Trinity Health Mid-atlantic Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093771271 PECOS PAC ID: 7416861885 Enrollment ID: O20040326000613 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Emergency Care Services Of Pennsylvania Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114955010 PECOS PAC ID: 1759301799 Enrollment ID: O20051206000046 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Jefferson Acute Care Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730571324 PECOS PAC ID: 7810215613 Enrollment ID: O20150407001063 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Keystone Medical Services Of Bradford Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396287991 PECOS PAC ID: 6901189562 Enrollment ID: O20170207000531 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Entity Name | Nazareth Physician Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285150458 PECOS PAC ID: 0941229017 Enrollment ID: O20171026001610 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Usaima Naveed Siddiqi, DO 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: (877) 668-5621 | Dr Usaima Naveed Siddiqi, DO 1606 N 7th St, Terre Haute, IN 47804 Ph: (812) 238-7523 |
News Archive
The ageing of society needs new, more cost-effective solutions to improve the life quality of patients and cut the burden that is placed on the social welfare system.
University of Kentucky College of Medicine researcher Sidney Whiteheart has been awarded a prestigious Outstanding Investigator Award from the National Heart, Blood and Lung Institute for his research on how platelets function in hemostasis and during immune responses.
Merck, known as MSD outside the United States and Canada, today announced results from a Phase 2b study evaluating two doses of its investigational house dust mite sublingual immunotherapy tablet (MK-8237). The data were presented for the first time during a late-breaking oral session at the 2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in San Diego.
CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced the first patients have been treated with its new EMBOTRAP II Revascularization Device since it became commercially available in the U.S. EMBOTRAP II is a next-generation stent retriever used to capture and remove life-threatening blood clots from the brain following an ischemic stroke.
› Verified 2 days ago
Dr. Anthony D Heavin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7000 Fax: 812-238-4508 | |
Dr. Anita Toussi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 704-661-4242 Fax: 704-841-3927 | |
Ronald E Leach, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7000 | |
Philip M Tenbrink, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7523 Fax: 812-238-7444 | |
Dr. Dorene G. Hojnicki, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 915 S Petercheff St, Terre Haute, IN 47803 Phone: 812-462-3217 | |
Mikal Ramadan, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7000 Fax: 812-238-7444 |